TITLE

Hormone therapy for younger women may not increase CHD risk during 5-7 years follow-up, but stroke risk was increased independent of age

PUB. DATE
October 2007
SOURCE
Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p137
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the author's perspective on the study "Postmenopausal hormone therapy (HT) and risk of cardiovascular disease by age and years since menopause." The author contends that the study showed that no justification exist for initiation of HT in older asymptomatic women as a preventive health strategy. He remarks that the study suggest that women less that 60 years of age who use HT in the menopausal transition are not at increased risk of breast cancer, heart attack or stroke.
ACCESSION #
27407691

 

Related Articles

  • HRT: MORE BAD NEWS. Carmichael, Mary // Newsweek (Atlantic Edition);8/18/2003 (Atlantic Edition), Vol. 142 Issue 7, p56 

    It's been more than a year since a study linked hormone-replacement therapy to a higher risk of cardiovascular disease--and sent millions of women into a panic. Since then, the treatment has been implicated in breast cancer and stroke, too. But it still appeals to women desperate to escape...

  • Hormone Replacement Therapy Linked to Breast Cancer. Webb, Sarah // Discover;Jan2008, Vol. 29 Issue 1, p34 

    The article discusses medical research conducted in 2007 regarding the use of hormone replacement therapy (HRT) in medicine. The suggestion of connections made by researchers regarding HRT and breast cancer and heart disease in women are discussed. Questions are raised regarding the confirmation...

  • Is Estrogen for You? Manson, Joann E.; Bassuk, Shari S. // Newsweek (Pacific Edition);5/8/2006 (Pacific Edition), Vol. 147 Issue 19, p46 

    The article discusses the risks of hormone therapy for menopausal women. The authors note that estrogen may be linked with an increased risk of heart disease. The authors also mention that hormone therapy is likely to be more beneficial for women who start therapy early in menopause. For...

  • A Fresh Look at a Hot Issue. Komaroff, Anthony L.; Grodstein, Francine // Newsweek (Pacific Edition);2/7/2005 (Pacific Edition), Vol. 145 Issue 6, p48 

    Discusses the complexities of deciding whether to try hormone therapy (HT), in light of findings by the Women's Health Initiative study that HT increased the risk of heart disease. Background on the study; Observation that estrogen has both beneficial and harmful effects on plaques of...

  • Review: Observational studies adjusting for socioeconomic status and lifestyle show no association between HRT and CAD. Colditz, Graham // ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p40 

    Examines the effectiveness of postmenopausal hormone replacement therapy for prevention of cardiovascular disease. Sources of data used in the study; Role of estrogens in atherogenesis.

  • HRT and Postmenopausal Blood Pressure. Sadovsky, Richard // American Family Physician;2/15/2002, Vol. 65 Issue 4, p701 

    Deals with hormone replacement therapy (HRT) and postmenopausal blood pressure. Cause for the potmenopausal increase in blood pressure; Effect of HRT on longitudinal increase in blood pressure associated with postmenopausal women; Other findings on healthy postmenopausal women.

  • Research Update.  // CMAJ: Canadian Medical Association Journal;10/20/98, Vol. 159 Issue 8, p914 

    Reports on news and information in the field of medicine. Study that found hormone replacement therapy with estrogen plus progestin is ineffective against the risk of heart attack; The risk that alcohol poses to women who are trying to conceive; Lack of prevention by the spermicide nonoxynol 9...

  • News in Brief.  // ASHA Leader;3/30/2004, Vol. 9 Issue 6, p3 

    The article provides information on the various developments in the field of audiology. A small pilot study funded by the National Institutes of Health suggest that women who undergo hormone-replacement therapy may run the risk of diminished hearing. The National Institute on Deafness and other...

  • Estrogen-Mediated Protection in Myocardial Ischemia-Reperfusion Injury. Booth, Erin A.; Lucchesi, Benedict R. // Cardiovascular Toxicology;2008, Vol. 8 Issue 3, p101 

    Before menopause, a woman has a relatively low risk for developing cardiovascular disease. After menopause, however, the risk increases nearly twofold and cardiovascular disease remains the number one cause of death among women. Observational trials and studies in animal models of cardiovascular...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics